Roger Song
Stock Analyst at Jefferies
(0.66)
# 3,760
Out of 4,732 analysts
41
Total ratings
23.53%
Success rate
-24.98%
Average return
Main Sectors:
Stocks Rated by Roger Song
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IGMS IGM Biosciences | Downgrades: Hold | $48 → $2 | $1.77 | +12.99% | 2 | Jan 10, 2025 | |
| BIOA BioAge Labs | Downgrades: Hold | $42 → $7 | $5.14 | +36.19% | 2 | Dec 9, 2024 | |
| REPL Replimune Group | Maintains: Buy | $16 → $19 | $10.14 | +87.38% | 1 | Dec 4, 2024 | |
| KURA Kura Oncology | Maintains: Buy | $32 → $28 | $7.26 | +285.67% | 2 | Nov 21, 2024 | |
| ACRS Aclaris Therapeutics | Upgrades: Buy | $2 → $7 | $2.57 | +172.37% | 1 | Nov 19, 2024 | |
| IRON Disc Medicine | Initiates: Buy | $89 | $58.25 | +52.80% | 1 | Oct 23, 2024 | |
| NVAX Novavax | Maintains: Buy | $31 → $25 | $8.40 | +197.62% | 2 | Oct 16, 2024 | |
| NRIX Nurix Therapeutics | Initiates: Buy | $41 | $19.14 | +114.21% | 1 | Oct 11, 2024 | |
| ZBIO Zenas BioPharma | Initiates: Buy | $35 | $7.85 | +345.86% | 1 | Oct 8, 2024 | |
| KNSA Kiniksa Pharmaceuticals International, | Initiates: Buy | $40 | $18.54 | +115.75% | 1 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $3.61 | +149.31% | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $129 | $85.30 | +51.23% | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $2.5 → $8 | $0.84 | +852.38% | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $97 | $75.84 | +27.90% | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $72 | $18.00 | +300.00% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $110 | $32.65 | +236.91% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $0.5 → $1 | $0.89 | +12.11% | 10 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $35 | $6.86 | +410.20% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $1.05 | +757.14% | 1 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $675 | $2.98 | +22,551.01% | 1 | Jan 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $5.01 | +59.68% | 2 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $0.26 | +1,438.46% | 2 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $2.01 | +944.78% | 1 | Sep 2, 2020 |
IGM Biosciences
Jan 10, 2025
Downgrades: Hold
Price Target: $48 → $2
Current: $1.77
Upside: +12.99%
BioAge Labs
Dec 9, 2024
Downgrades: Hold
Price Target: $42 → $7
Current: $5.14
Upside: +36.19%
Replimune Group
Dec 4, 2024
Maintains: Buy
Price Target: $16 → $19
Current: $10.14
Upside: +87.38%
Kura Oncology
Nov 21, 2024
Maintains: Buy
Price Target: $32 → $28
Current: $7.26
Upside: +285.67%
Aclaris Therapeutics
Nov 19, 2024
Upgrades: Buy
Price Target: $2 → $7
Current: $2.57
Upside: +172.37%
Disc Medicine
Oct 23, 2024
Initiates: Buy
Price Target: $89
Current: $58.25
Upside: +52.80%
Novavax
Oct 16, 2024
Maintains: Buy
Price Target: $31 → $25
Current: $8.40
Upside: +197.62%
Nurix Therapeutics
Oct 11, 2024
Initiates: Buy
Price Target: $41
Current: $19.14
Upside: +114.21%
Zenas BioPharma
Oct 8, 2024
Initiates: Buy
Price Target: $35
Current: $7.85
Upside: +345.86%
Kiniksa Pharmaceuticals International,
Sep 13, 2024
Initiates: Buy
Price Target: $40
Current: $18.54
Upside: +115.75%
Sep 5, 2024
Initiates: Buy
Price Target: $9
Current: $3.61
Upside: +149.31%
Sep 3, 2024
Maintains: Buy
Price Target: $108 → $129
Current: $85.30
Upside: +51.23%
May 6, 2024
Upgrades: Buy
Price Target: $2.5 → $8
Current: $0.84
Upside: +852.38%
Apr 17, 2024
Initiates: Buy
Price Target: $97
Current: $75.84
Upside: +27.90%
Mar 20, 2024
Maintains: Buy
Price Target: $41 → $72
Current: $18.00
Upside: +300.00%
Mar 7, 2024
Initiates: Buy
Price Target: $110
Current: $32.65
Upside: +236.91%
Mar 6, 2024
Maintains: Hold
Price Target: $0.5 → $1
Current: $0.89
Upside: +12.11%
Aug 31, 2022
Maintains: Buy
Price Target: $30 → $35
Current: $6.86
Upside: +410.20%
Jul 29, 2022
Initiates: Buy
Price Target: $9
Current: $1.05
Upside: +757.14%
Jan 11, 2022
Initiates: Buy
Price Target: $675
Current: $2.98
Upside: +22,551.01%
Dec 1, 2021
Initiates: Buy
Price Target: $8
Current: $5.01
Upside: +59.68%
Nov 12, 2021
Upgrades: Buy
Price Target: $3 → $4
Current: $0.26
Upside: +1,438.46%
Sep 2, 2020
Initiates: Buy
Price Target: $21
Current: $2.01
Upside: +944.78%